A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 35/14 (2006.01) A61M 1/38 (2006.01) A61P 37/06 (2006.01) B01D 15/00 (2006.01)
Patent
CA 2116138
Antibody-mediated xenograft rejection is attenuated by (i) removing preformed antibodies to various identified carbohydrate xenoantigens from the recipient's cieculation prior to transplantation by extracorporeal perfusion of the recipient's blood over a biocompatible solid support to which the xenoantigens are bound and/or (2) parenterally administering a xenoantibody-inhibiting amount of an identified xenoantigen to the recipient shortly before graft revascularization and thereafter.
Cooper David K. C.
Good Heather A.
Malcolm Andrew J.
Alberta Research Council
Alberta Research Council Inc.
Baptist Medical Center Of Oklahoma Inc.
Integris Baptist Medical Center Inc.
Torys Llp
LandOfFree
Methods and compositions for attenuating antibody-mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for attenuating antibody-mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for attenuating antibody-mediated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1576873